---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-26-007422"
form_type: "8-K"
ticker: "FLNA"
cik: "0001069530"
company_name: "FILANA THERAPEUTICS, INC."
filed_at: "2026-03-10T23:59:59+00:00"
generated_at: "2026-05-15T15:27:31.744440+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Cassava Sciences renames to Filana Therapeutics; new ticker FLNA effective March 11

## Summary
- Company changed legal name to Filana Therapeutics, Inc. effective March 10, 2026.
- Common stock begins trading on Nasdaq under ticker FLNA on March 11, 2026.
- New name reflects strategic focus on modulating filamin A protein for CNS disorders like TSC-related epilepsy.
- Amended bylaws modernize provisions for meetings, advance notice, director terms, and uncertificated shares.
- No changes to restated certificate of incorporation beyond the name change.

## SEC filing metadata
- accession: 0001437749-26-007422
- form_type: 8-K
- ticker: FLNA
- cik: 0001069530
- company_name: FILANA THERAPEUTICS, INC.
- filed_at: 2026-03-10T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.03, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1069530/000143774926007422/0001437749-26-007422-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1069530/000143774926007422/sava20260307_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-26-007422
- JSON: https://secwatch.observer/filing/0001437749-26-007422.json
- Plain text: https://secwatch.observer/filing/0001437749-26-007422.txt

## Source-grounded claims
- claim_id: a00733decfcff46d69f2a28cecf284902df4ddfe
  claim: FILANA THERAPEUTICS, INC.: Adopted amended and restated By-Laws reflecting the name change and clarifying provisions on stockholder and board meetings, advance notice, director terms, special meetings, inspectors of election, and uncertificated shares (effective 2026-03-10).
  evidence_excerpt: The Company’s board of directors also adopted amended and restated By-Laws of the Company (“Amended By-Laws”) reflecting the Name Change, effective as of March 10, 2026.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1069530/000143774926007422/0001437749-26-007422-index.htm
- claim_id: f786e8df7fae0905de4279928facaeb5fadf5280
  claim: FILANA THERAPEUTICS, INC.: Company changed its legal name to Filana Therapeutics, Inc. via amendment to Restated Certificate of Incorporation (effective 2026-03-10).
  evidence_excerpt: Effective March 10, 2026, Cassava Sciences, Inc. changed its legal name (the “Name Change”) to Filana Therapeutics, Inc. (the “Company”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1069530/000143774926007422/0001437749-26-007422-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.